Efficacy of antimicrobial peptoids against Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 6, 2011, Pages 3058-3062

  Kapoor, Rinki ^a   Eimerman, Patrick R ^a   Hardy, Jonathan W ^a   Cirillo, Jeffrey D ^b   Contag, Christopher H ^a   Barron, Annelise E ^a,c  

^a STANFORD UNIVERSITY   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c Stanford University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GENTAMICIN; OLIGOPEPTOID DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CYTOTOXICITY; DRUG EFFICACY; DRUG STRUCTURE; HOST RESISTANCE; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE; CELL SURVIVAL; MACROPHAGES; MICE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PEPTOIDS;

EID: 79956322803     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01667-10     Document Type: Article

References (30)

1. Arnt, L., and G. N. Tew. 2002. New poly(phenyleneethynylene)s with cationic, facially amphiphilic structures. J. Am. Chem. Soc. 124:7664-7665.
2. Bessalle, R., A. Kapitkovsky, A. Gorea, I. Shalit, and M. Fridkin. 1990. All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett. 274:151-155. (Pubitemid 20378143)
3. Brennan, P. J., and H. Nikaido. 1995. The envelope of mycobacteria. Annu. Rev. Biochem. 64:29-63.
4. Brogden, K. A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
5. Chongsiriwatana, N. P., et al. 2011. Short alkylated peptoid mimics of antimicrobial lipopeptides. Antimicrob. Agents Chemother. 55:417-420.
6. Chongsiriwatana, N. P., et al. 2008. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc. Natl. Acad. Sci. U. S. A. 105:2794-2799.
7. Collins, L., and S. G. Franzblau. 1997. Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 41:1004-1009.
8. Contag, C. H., et al. 1995. Photonic detection of bacterial pathogens in living hosts. Mol. Microbiol. 18:593-603.
9. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project. JAMA 282:677-686.
10. Glickman, M. S., and W. R. Jacobs, Jr. 2001. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell 104:477-485.
11. Hale, J. D., and R. E. Hancock. 2007. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev. Anti Infect. Ther. 5:951-959.
12. Hancock, R. E., and H. G. Sahl. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557.
13. Hess, J., et al. 1998. Mycobacterium bovis bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes. Proc. Natl. Acad. Sci. U. S. A. 95:5299-5304.
14. Johnson, R., et al. 2006. Drug resistance in Mycobacterium tuberculosis. Curr. Issues Mol. Biol. 8:97-111.
15. Kaufmann, S. H. 2000. Is the development of a new tuberculosis vaccine possible? Nat. Med. 6:955-960.
16. Kirshenbaum, K., et al. 1998. Sequence-specific polypeptoids: a diverse family of heteropolymers with stable secondary structure. Proc. Natl. Acad. Sci U. S. A. 95:4303-4308.
17. Kunin, C. M. 1993. Resistance to antimicrobial drugs - a worldwide calamity. Ann. Intern. Med. 118:557-561.
18. Méndez-Samperio, P. 2008. Role of antimicrobial peptides in host defense against mycobacterial infections. Peptides 29:1836-1841.
19. Miller, S. M., S. R. J. S. Ng, R. N. Zuckermann, J. M. Kerr, W. H. Moos. 1995. Comparison of the proteolytic susceptibilities of homologous L-amino acid, D-amino acid, and N-substituted glycine peptide and peptoid oligomers. Drug Dev. Res. 35:20-32.
20. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63. (Pubitemid 14203433)
21. Patch, J. A., and A. E. Barron. 2002. Mimicry of bioactive peptides via non-natural, sequence-specific peptidomimetic oligomers. Curr. Opin. Chem. Biol. 6:872-877.
22. Peggion, C., et al. 2003. Trichogin: a paradigm for lipopeptaibols. J. Pept. Sci. 9:679-689.
23. Porter, E. A., B. Weisblum, and S. H. Gellman. 2002. Mimicry of host-defense peptides by unnatural oligomers: antimicrobial beta-peptides. J. Am. Chem. Soc. 124:7324-7330.
24. Raviglione, M. C., D. E. Snider, Jr., and A. Kochi. 1995. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273:220-226.
25. Sanborn, T. J., C. W. Wu, R. N. Zuckermann, and A. E. Barron. 2002. Extreme stability of helices formed by water-soluble poly-N-substituted glycines (polypeptoids) with alpha-chiral side chains. Biopolymers 63:12-20.
26. Shai, Y. 2002. Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236-248. (Pubitemid 36098316)
27. Tsubery, H., I. Ofek, S. Cohen, and M. Fridkin. 2001. N-terminal modifications of polymyxin B nonapeptide and their effect on antibacterial activity. Peptides 22:1675-1681. (Pubitemid 32918247)
28. Vemulapalli, R., Y. He, S. M. Boyle, N. Sriranganathan, and G. G. Schurig. 2000. Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses. Infect. Immun. 68:3290-3296.
29. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395. (Pubitemid 34100944)
30. Zuckermann, R., J. M. Kerr, S. B. H. Kent, and W. H. Moos. 1992. Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis. J. Am. Chem. Soc. 114:10646-10647.